Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
Through this collaboration, Boehringer Ingelheim will work with Healthy.io's Minuteful Kidney™ test kit to explore the operational aspects of an at-home UACR (urine albumin-to-creatinine ratio) test kit – the first and only FDA-cleared, smartphone powered at-home ACR test – to at-risk, previously untested patients.
- Through this collaboration, Boehringer Ingelheim will work with Healthy.io's Minuteful Kidney™ test kit to explore the operational aspects of an at-home UACR (urine albumin-to-creatinine ratio) test kit – the first and only FDA-cleared, smartphone powered at-home ACR test – to at-risk, previously untested patients.
- This will help engage these patients in their kidney health by conducting a smartphone-powered test at the time and place of their choosing as a step-in screening for earlier identification of CKD.
- "Minuteful Kidney is a catalyst to increase ACR testing at scale and support early detection of CKD," said Paula LeClair, U.S. General Manager at Healthy.io.
- Yet most don't know they have the condition until it progresses to end-stage renal disease (ESRD), eventually requiring dialysis and/or a kidney transplant.